Trials / Completed
CompletedNCT01918371
A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 323 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This retrospective data review study will evaluate anti-VEGF injections for retinal vein occlusion (RVO) or diabetic macular edema (DME).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anti-VEGF | Patients with retinal vein occlusion or diabetic macular edema receiving anti-VEGF injection(s) in accordance with standard of care practices. This is a retrospective chart review study. |
Timeline
- Start date
- 2013-08-02
- Primary completion
- 2014-09-04
- Completion
- 2014-09-04
- First posted
- 2013-08-07
- Last updated
- 2019-04-18
- Results posted
- 2016-05-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01918371. Inclusion in this directory is not an endorsement.